PHADIA Varelisa Cardiolipin IgM Cardiolipin autoantibody immunological test system (IgM class antibodies)
Hazard
Customers were not following the labeled assay procedure. This was due to a letter issued to them in 2004 from Phadia GmbH, which indicated that customers could omit the pre-wash step. The omission of the pre-wash step, when combined with a change in material source in kit lot #0067, caused elevated results.
What You Should Do
Remedy
On 8/2/2012 an URGENT PRODUCT CORRECTION INFORMATION FOR PHADIA VARELISA CARDIOLIPIN IGM, Article Number 15696 letter was sent to all consignees the received the Direction for Use modification letter in 2004.
Affected by this recall?
Get a free legal consultation about this recall.
Talk to a Lawyer →Affiliate link
Products
PHADIA Varelisa Cardiolipin IgM
Cardiolipin autoantibody immunological test system (IgM class antibodies)
- Brand
- Phadia US Inc
- UPC
- Article Number 15696 Lot number #0067
Units Affected
837 kits (96 assays per kit), total of 80,352 individual assays